-
IPO Watch: Sudeep Pharma files draft papers with SEBI to raise funds via IPO
25 Jun 2025 13:57 GMT
… of India (SEBI), for an initial public offering (IPO).
Sudeep Pharma, since it was … clients such as Pfizer Inc, Intas Pharmaceuticals Limited, Mankind Pharma Limited, Merck … ₹94.54 crore, respectively.
The initial public offering (IPO), with a nominal value of …
-
Sudeep Pharma files draft papers with Sebi to mop up funds via IPO
25 Jun 2025 11:44 GMT
… funds through an initial public offering (IPO).
The IPO is a combination … company plans a pre-IPO placement of shares aggregating … . If the pre-IPO placement is completed, … marquee customers, including Pfizer, Intas Pharmaceuticals, Mankind Pharma, Merck Group …
-
Innova Captab files DRHP with SEBI to raise funds via IPO
08 Sep 2022 08:55 GMT
… to raise funds through an initial public offering (IPO).
The issue with a face … Emcure Pharmaceuticals Limited, Lupin Limited, Intas Pharmaceuticals Limited, Leeford Healthcare Limited, Medley …
Keywords
InnovaCaptab
DRHP
SEBI
IPO
FundRaising
PharmaCompany
-
Rare Enterprises and Quadria Capital-backed Concord Biotech files DRHP for IPO
08 Sep 2022 08:54 GMT
… ), to raise funds through an initial public offering (IPO).
The issue with a face … 's API clients include Intas Pharmaceuticals Limited and Glenmark Pharmaceuticals Limited … Bulls
Keywords
ConcordBiotech
DRHP
SEBI
IPO
FundRaising
-
Rare Enterprises, Quadria-backed Concord Biotech files draft IPO papers with Sebi
16 Aug 2022 11:23 GMT
… has filed draft papers for IPO with market regulator Sebi.
The … 's API clients include Intas Pharmaceuticals and .
As of March 31 …
-
5 pharma/healthcare IPOs to raise over Rs 8,000 cr this month
02 Aug 2021 12:45 GMT
… companies are tapping the initial public offering (IPO) market over the next … 27,052 crore through IPOs in the first four … and 45 main-board IPOs collectively mobilising Rs 82 … Pharmaceuticals, Eris Lifesciences, and Intas Pharmaceuticals among others, and had …
-
Smaller cheques, sharper bets: Healthcare deals hold steady in Q1 2025
23 Apr 2025 17:50 GMT
… transactions in the space—including Intas Pharmaceuticals’ $558 million acquisition of Coherus … private equity deals this quarter.
IPOs signal institutional optimism
Three healthcare … IPOs, raising a total of $503 …
-
Pharma & healthcare deals see shifting focus on scalable, global models: Grant Thornton Bharat
23 Apr 2025 13:34 GMT
… , according to the report.
Excluding IPOs and QIPs, the quarter saw … deal of the quarter was Intas Pharmaceuticals’ $558 million acquisition of Udenyca …
-
Top biotech deals of February 2025
06 Mar 2025 21:42 GMT
… bagged $250 million in an initial public offering.
Biotech deals by approach in … -Thera Solutions and Indian biotech Intas Pharmaceuticals have partnered to license BAT2506 …
-
Hurun India 500 list: NSE, Serum Institute, Zerodha among most valuable unlisted companies; check top 10 list here
19 Feb 2025 15:16 GMT
… as it prepares for its initial public offering (IPO).
As per the 2024 Burgundy … list released on Tuesday, the IPO-bound NSE has reportedly resumed … ,860
Parle Products
68,640
Intas Pharmaceuticals
68,150
Dream11
67,860 …
About
© 1995-2025